Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.34 USD | +6.35% | +2.29% | +14.53% |
04-16 | Clearside Biomedical, Inc Appoints Anthony S. Gibney to its Board of Directors | CI |
03-18 | Clearside Biomedical Names Victor Chong Chief Medical Officer | MT |
Sales 2024 * | 2.74M 220M | Sales 2025 * | 7.36M 589M | Capitalization | 100M 8.02B |
---|---|---|---|---|---|
Net income 2024 * | -39M -3.12B | Net income 2025 * | -43M -3.44B | EV / Sales 2024 * | 28.8 x |
Net cash position 2024 * | 21.26M 1.7B | Net Debt 2025 * | 12.33M 987M | EV / Sales 2025 * | 15.3 x |
P/E ratio 2024 * |
-2.55
x | P/E ratio 2025 * |
-2.31
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.7% |
Latest transcript on Clearside Biomedical, Inc.
1 day | +6.35% | ||
1 week | +2.29% | ||
Current month | -12.42% | ||
1 month | -20.71% | ||
3 months | +8.94% | ||
6 months | +97.06% | ||
Current year | +14.53% |
Managers | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 07/08/17 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 31/12/11 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 13/06/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 07/08/17 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 25/09/18 |
Christy Shaffer
BRD | Director/Board Member | 66 | 31/12/11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.34 | +6.35% | 154,219 |
25/04/24 | 1.26 | -5.97% | 135,399 |
24/04/24 | 1.34 | -2.19% | 201,427 |
23/04/24 | 1.37 | -2.84% | 232,166 |
22/04/24 | 1.41 | +7.63% | 299,484 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.53% | 100M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CLSD Stock